BE CAREFUL!!
I'm getting bad vibes on the news for tomorrow in this one. This is based on my dowsing work and it suggests a drop of 38%. That would rock it down to about $42.50
FYI I don't know anything about the fundamentals or background on this pending approval, and I really don't know anything about the company, nor do I care.
I'm not super confident yet in estimating percent moves, and this is only my second FDA prediction, so we'll see.
I'm getting bad vibes on the news for tomorrow in this one. This is based on my dowsing work and it suggests a drop of 38%. That would rock it down to about $42.50
FYI I don't know anything about the fundamentals or background on this pending approval, and I really don't know anything about the company, nor do I care.
I'm not super confident yet in estimating percent moves, and this is only my second FDA prediction, so we'll see.
Pesanan dibatalkan
I have a completely opposite reading for this today and it's very bullish. So we'll just have to wait and see.Nota
So, what would've happened if it wasn't approved??? LOLNo wonder I had mixed vibes today. This was a good one to learn from. Curious to find out where it stops.
Is this typical kind of action with these FDA releases??? I'd appreciate any input. TYIA
Nota
Up 6% today with indexes down 3%. Now the bullish reading makes sense! Really interesting.Nota
Looks like the original reading of a $42.50 area target/38% down is how this goes.Nota
ES up 2% and this thing only up 1.7% atm after being up 5% earlier. Still sell rallies.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.